Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I - Related Studies

Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I

This study has been completed.

Study NCT00001905. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Adhesions
		Leukocyte-Adhesion Deficiency Syndrome
		Syndrome

2	More general conditions related to this trial
		Disease
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Pathologic Processes

3	Interventions listed in this trial
		Interferon gamma

4	Additional drug interventions recognized in this trial
		Interferon Alfa-2b
		Interferon Type II
		Interferon-gamma, Recombinant
		Interferons

5	More general drug interventions related to this trial
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Anti-Infective Agents
		Antineoplastic Agents
		Antiviral Agents
		Growth Inhibitors
		Growth Substances
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)